Synthesis of Substituted Heterocyclic Thiourea Compounds

References

• Cantrell , A. S. , Engelhardt , P. , Hogberg , M. , Jaskunas , S. R. , Johansson , N. G. , Jordan , C. L. , Kangasmetsa , J. , Kinnick , M. D. , Lind , P. , Morin , J. M. Jr. , Muesing , M. A. , Noreen , R. , Oberg , B. , Pranc , P. , Sahlberg , C. , Ternansky , R. J. , Vasileff , R. T. , Vrang , L. , West , S. J. and Zhang , H. 1996 . Phenethylthiazolylthiourea (PETT) compounds: A new class of HIV‐1 reverse transcriptase inhibitors, 1: Synthesis and further structure–activity relationship studies of PETT anlogs . J. Med. Chem. , 39 : 4261 – 4274 .
   PubMed Web of Science ®Google Scholar
• Bell , F. W. , Cantrell , A. S. , Hogberg , M. , Jaskunas , S. R. , Johansson , N. G. , Jordan , C. L. , Kinnick , M. D. , Lind , P. , Morin , J. M. Jr. , Noreen , R. , Oberg , B. , Palkowitz , J. A. , Parrish , C. A. , Pranc , P. , Sahlberg , C. , Ternansky , R. T. , Vasileff , R. T. , Vrang , L. , West , S. J. , Zhang , H. and Zhou , X. X. 1995 . Phenethylthiazolylthiourea (PETT) compounds: A new class of HIV‐1 reverse transcriptase inhibitors, 1: Synthesis and basic structure–activity relationship studies of PETT anlogs . J. Med. Chem. , 38 : 4929 – 4936 .
   PubMed Web of Science ®Google Scholar
• Mao , C. , Vig , R. , Venkatachalam , T. K. , Sudbeck , E. A. and Uckun , F. M. 1998 . Structure based design of N‐[2‐(1‐piperidinyl ethyl)]‐N′‐[2‐(‐5‐bromopyridyl)]‐thiourea and N‐[2‐(1‐piperazinylethyl0]‐N′‐[2‐(5‐bromopyridyl)]‐thiourea as potent non‐nucleoside inhibitors of HIV‐1 reverse transcriptase . Bioorg. Med. Chem. Lett. , 8 : 2213 – 2218 .
   PubMed Web of Science ®Google Scholar
• Mao , C. , Sudbeck , E. A. , Venkatachalam , T. K. and Uckun , F. M. 1999 . Rational design of N‐[2‐(2,5‐dimethoxy phenylethyl)]‐N′‐[2‐(5‐bromopyridyl)]‐thiourea (HI‐236) as a potent non‐nucleoside inhibitor of drug‐resistant human immunodeficiency virus . Bioorg. Med. Chem. Lett. , 9 : 1593 – 1598 .
   PubMed Web of Science ®Google Scholar
• Mao , C. , Sudbeck , E. A. , Venkatachalam , T. K. and Uckun , F. M. 2000 . Structure‐based drug design of non‐nucleoside inhibitors for wild‐type and drug resistant HIV reverse transcriptase . Biochem. Pharmacol. , 60 : 1251 – 1265 .
   PubMed Web of Science ®Google Scholar
• Uckun , F. M. , Mao , C. , Pendergrass , S. , Maher , D. , Zhu , D. , Tuel‐Ahlgren , L. and Venkatachalam , T. K. 1999 . N‐[2‐(1‐Cyclohexenyl) ethyl]‐N′‐[2‐(5‐bromopyridyl)]‐thiourea and N‐[2‐(1‐cyclohexenyl)ethyl]‐N′‐[2‐(5‐chloropyridyl)]‐thiourea as potent inhibitors of multi‐drug resistant human immunodeficiency virus–1 . Bioorg. Med. Chem. Lett. , 9 : 2721 – 2726 .
   PubMed Web of Science ®Google Scholar
• Uckun , F. M. , Mao , C. , Pendergrass , S. , Maher , D. , Zhu , D. , Tuel‐Ahlgren , L. and Venkatachalam , T. K. 2000 . N‐[2‐(4‐methylphenyl) ethyl]‐N′‐[2‐(5‐bromopyridyl)]‐thiourea as a potent inhibitor of NNRTI resistant and multi‐drug resistant human immunodeficiency virus . Antiviral. Chem. Chemother. , 11 : 135 – 140 .
   PubMed Web of Science ®Google Scholar
• Uckun , F. M. , Pendergrass , S. , Maher , D. , Zhu , D. , Tuel‐Ahlgren , L. , Mao , C. and Venkatachalam , T. K. 1999 . N‐[2‐(2‐Thiophene)ethyl]‐N′‐[2‐(5‐bromopyridyl)]‐thiourea as a potent inhibitor of NNI‐resistant and multi‐drug resistant human immunodeficiency virus–1 . Bioorg. Med. Chem. Lett. , 9 : 3411 – 3416 .
   PubMed Web of Science ®Google Scholar
• Vig , R. , Mao , C. , Venkatachalam , T. K. , Tuel‐Ahlgren , L. , Sudbeck , E. A. and Uckun , F. M. 1998 . 5‐Alkyl‐2‐[(methylthiomethyl)thio]‐6‐[(benzyl)‐pyrimidin‐4‐(1H)‐ones as potent non‐nucleoside reverse transcriptase inhibitors of S‐DABO series . Bioorg. Med. Chem. Lett. , 8 : 1461 – 1466 .
   PubMed Web of Science ®Google Scholar
• Venkatachalam , T. K. and Uckun , F. M. 2004 . Synthesis of β‐fluorophenethyl halopyridyl thiourea compounds as non‐nucleoside inhibitors of HIV‐1 reverse transcriptase . Synth. Commun. , 34 : 2462 – 2472 .
   Web of Science ®Google Scholar
• Venkatachalam , T. K. and Uckun , F. M. 2004 . Regiospecific synthesis of 5‐halo‐substituted thiophene pyridyl thiourea compounds as non‐nucleoside inhibitors of HIV‐1 reverse transcriptase . Synth. Commun. , 34 : 1 – 11 .
   Web of Science ®Google Scholar
• Mallikarjun , P. , Venkatachalam , T. K. and Uckun , F. M. 2003 . Introduction of carbohydrate moiety into the structure of thiourea compounds targeting HIV‐1 reverse transcriptase . Synth. Commun. , 33 : 1185 – 1193 .
   Web of Science ®Google Scholar
• Venkatachalam , T. K. , Mao , C. and Uckun , F. M. 2004 . Effect of stereo and regiochemistry towards wild and multidrug resistant HIV‐1 virus: Viral potency of chiral PETT derivatives . Biochem. Pharmacol. , 67 : 1933 – 1946 .
   PubMed Web of Science ®Google Scholar
• Venkatachalam , T. K. , Mao , C. and Uckun , F. M. 2004 . Effect of stereochemistry on the anti‐HIV activity of chiral thiourea compounds . Bioorg. Med. Chem. , 12 : 4275 – 4284 .
   PubMed Web of Science ®Google Scholar
• Venkatachalam , T. K. , Mao , C. and Uckun , F. M. 2001 . Stereochemistry as a major determinant of the anti‐HIV activity of chiral naphthyl thiourea compounds . Antivir. Chem. Chemother. , 12 : 213 – 221 .
   PubMed Web of Science ®Google Scholar
• Venkatachalam , T. K. , Sudbeck , E. A. , Mao , C. and Uckun , F. M. 2000 . Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as non‐nucleoside inhibitors of HIV‐1 reverse transcriptase . Bioorg. Med. Chem. Lett. , 10 : 2071 – 2074 .
   PubMed Web of Science ®Google Scholar
• Wallingford , V. H. and Krueger , P. A. 1957 . Organic Synthesis Vol. II , 349 – 351 . New York : John Wiley & Sons . Collect
   Google Scholar
• Fieser , L. F. and Fieser , M. 1967 . Reagents for Organic Synthesis Vol. 1 , 1151 – 1152 . New York : John Wiley & Sons .
   Google Scholar